Haemonetics Corporation (HAE) Q4 2017 Earnings Results

Haemonetics Corp Misses on EPS, Stock Down 0.6%

Haemonetics Corp's earnings report showed an EPS of $0.39, but there was no revenue information available. The stock reacted negatively, declining by 0.6%. The lack of guidance and specific revenue details may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.39	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management maintained a neutral tone during the call. They did not provide specific guidance or insights into future performance.

Management did not provide specific insights on revenue performance.

No updates on future expectations were shared during the call.

Haemonetics Corp Misses on EPS, Stock Down 0.6%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Misses on EPS, Stock Down 0.6%

Key numbers

Management commentary